|
Market Closed -
Boerse Muenchen
16:43:54 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 19.50 EUR | -0.51% |
|
-1.01% | -53.33% |
| Market Cap | 713M 635M 592M 539M 1.02B 68.63B 1.02B 7.15B 2.78B 35B 2.68B 2.62B 113B | P/E 2026 * |
13.1x | P/E 2027 * | 6.57x |
|---|---|---|---|---|---|
| Enterprise Value | 1.56B 1.39B 1.3B 1.18B 2.23B 151B 2.24B 15.69B 6.1B 76.81B 5.87B 5.74B 247B | EV / Sales 2026 * |
1.87x | EV / Sales 2027 * | 1.49x |
| Free-Float |
77.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COLL | Delayed | |
CBOE
| COLL | Real-time | |
|
Deutsche Boerse AG
| 354 | Delayed | |
|
Börse Stuttgart
| 354 | Delayed | |
|
Boerse Muenchen
| 354 | Real-time | |
|
Tradegate
| 354 | Real-time |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 week | -1.01% | ||
| Current month | +1.03% | ||
| 1 month | -5.77% | ||
| 3 months | -39.51% | ||
| 6 months | -30.05% | ||
| Current year | -53.33% |
| 1 week | 19.2 |  | 20.2 |
| 1 month | 18.9 | | 20.8 |
| 3 years | 18.9 | | 42.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 2024-11-11 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 2021-05-23 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 2022-03-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 2025-05-14 |
John Freund
BRD | Director/Board Member | 72 | 2014-01-31 |
Garen Bohlin
BRD | Director/Board Member | 78 | 2014-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -1.01% | -33.33% | -9.26% | 717M | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| Average | -0.33% | -3.54% | +19.59% | +51.43% | 410.8B | |
| Weighted average by Cap. | -0.15% | -3.54% | +28.49% | +70.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 837M 746M 695M 633M 1.19B 80.62B 1.2B 8.4B 3.26B 41.11B 3.14B 3.07B 132B | 850M 758M 706M 643M 1.21B 81.87B 1.22B 8.53B 3.32B 41.75B 3.19B 3.12B 134B |
| Net income | 61.01M 54.37M 50.68M 46.13M 86.95M 5.88B 87.49M 612M 238M 3B 229M 224M 9.63B | 130M 116M 108M 98.41M 185M 12.53B 187M 1.31B 507M 6.39B 489M 478M 20.55B |
| Net Debt | 851M 759M 707M 644M 1.21B 81.99B 1.22B 8.54B 3.32B 41.81B 3.2B 3.13B 134B | 553M 493M 459M 418M 788M 53.26B 793M 5.55B 2.16B 27.16B 2.08B 2.03B 87.32B |
| Date | Price | Change |
|---|---|---|
| 26-10-05 | €19.50 | -0.51% |
| 26-10-02 | €19.60 | +0.51% |
| 26-10-01 | €19.50 | +0.52% |
| 26-09-30 | €19.40 | 0.00% |
| 26-09-29 | €19.40 | -2.51% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
Select your edition
All financial news and data tailored to specific country editions
